Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02589717
Title An Expanded Access Study of MPDL3280A in Patients With PD-L1-Positive Locally Advanced or Metastatic Urothelial Bladder Cancer After Failure With Platinum-Containing Chemotherapy
Recruitment Approved for marketing
Gender both
Phase FDA approved
Variant Requirements Yes
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST